\begin{table}
\centering
\caption{\label{tab:robustness}Robustness Checks}
\centering
\resizebox{\ifdim\width>\linewidth\linewidth\else\width\fi}{!}{
\begin{threeparttable}
\begin{tabular}[t]{llll}
\toprule
Specification & Estimate & SE & N\\
\midrule
Main (all clinicians, $\geq$4 claims/qtr) & 0.0616 & (0.2217) & 509,328\\
Sun-Abraham ATT (interaction-weighted) & -0.0602 & (0.0598) & 509,327\\
Full-time threshold ($\geq$36 claims/qtr) & 0.0580 & (0.2067) & 509,328\\
Binary treatment (early vs.\ late) & 0.0462 & (0.0414) & 509,328\\
With Medicaid share $\times$ time & 0.0717 & (0.2188) & 509,328\\
\addlinespace
Medicaid pop denominator (desert) & 0.0021 & (0.0931) & 509,328\\
Region $\times$ quarter FE & 0.1917 & (0.2559) & 509,328\\
Total claims (log) as outcome & 0.3175 & (0.9712) & 509,328\\
No NP/PA (excl.\ nurse practitioners/PAs) & 0.1049 & (0.2122) & 509,328\\
Placebo (fake 2021Q2 treatment) & 0.0191 & (0.4972) & 400,626\\
\bottomrule
\end{tabular}
\begin{tablenotes}
\item \textit{Note: } 
\item All models include county$\times$specialty and quarter fixed effects with state-clustered standard errors (51 clusters) unless noted. Placebo test uses only pre-unwinding observations; N varies because states have different unwinding start dates. Randomization inference (500 permutations of treatment timing across states) yields p = 0.796 for the main specification.
\end{tablenotes}
\end{threeparttable}}
\end{table}
